Skip to main content
SpringerLink
Log in

Comparative Risk-Benefit Assessment of Drugs Used in the Management of Hypertension in Pregnancy

  • Review Article
  • Risk-Benefit Assessment
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Antihypertensive treatment in pregnancy is needed to protect the mother from the dangers of severe hypertension (≥170/110mm Hg), particularly cerebral haemorrhage in the context of preeclampsia. There is no evidence that treatment of the hypertension confers any other benefit; the onset and progression of preeclampsia is neither prevented nor ameliorated. Therefore, there are no indications for treating mild-to-moderate hypertension (140 to 169/90 to 109mm Hg).

Intravenous hydralazine and oral nifedipine are effective drugs to treat severe hypertension acutely, the latter having the advantage of ease of administration. For long term therapy, methyldopa is the only drug which has been fully assessed and shown to be safe for the neonate and infant. β-Adrenoceptor antagonists are safe to use in the third trimester but cause significant intrauterine growth retardation when used for longer periods. ACE inhibitors are contraindicated and diuretics should be avoided. Although calcium antagonists appear to have much potential they require further assessment of their use in pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahokas RA, Sibai BM, Mabie WC, Anderson GD. Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat. American Journal of Obstetrics and Gynecology 159: 1440–1445, 1988

    PubMed  CAS  Google Scholar 

  • Andersson KE, Ingemarsson I, Ulmsten U, Wingerup L. Inhibition of prostaglandin-induced uterine activity by nifedipine. British Journal of Obstetrics and Gynaecology 86: 175–179, 1979

    Article  PubMed  CAS  Google Scholar 

  • Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pree-clampsia by early antiplatelet therapy. Lancet 1: 840–842, 1985

    Article  PubMed  CAS  Google Scholar 

  • Broughton-Pipkin F, Symonds EM, Turner SR. The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. Journal of Physiology 323: 415–422, 1982

    PubMed  CAS  Google Scholar 

  • Broughton-Pipkin F, Turner SR, Symonds EM. Possible risk with captopril in pregnancy: some animal data. Lancet 1: 1256, 1980

    Article  PubMed  CAS  Google Scholar 

  • Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. British Medical Journal 301: 587–589, 1990

    Article  PubMed  CAS  Google Scholar 

  • Braunwald E. Mechanism of action of calcium-channel-blocking drugs. New England Journal of Medicine 307: 1618–1627, 1982

    Article  PubMed  CAS  Google Scholar 

  • Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM. Incidence of a positive direct Coombs’ test in patients on α-methyldopa. Lancet 2: 133–135, 1966

    Article  PubMed  CAS  Google Scholar 

  • Cockburn J, Moar VA, Ounsted M, Redman CWG. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1: 647–649, 1982

    Article  PubMed  CAS  Google Scholar 

  • Collins R, Wallenburg HCS. Pharmacological prevention and treatment of hypertensive disorders in pregnancy. In Chalmers et al. (Eds) Effective care in pregnancy and childbirth, 1st ed., Vol. 1, pp. 512–533, Oxford University Press, Oxford, 1989

    Google Scholar 

  • Collins R, Yusif S, Peto R. Overview of randomised trials of diuretics in pregnancy. British Medical Journal 290: 17–23, 1985

    Article  PubMed  CAS  Google Scholar 

  • Constantine G, Beevers DG, Reynolds AL, Luesley DM. Nifedipine as a second line antihypertensive drug in pregnancy. British Journal of Obstetrics and Gynaecology 94: 1136–1142, 1987

    Article  PubMed  CAS  Google Scholar 

  • Dale J, Landmark KH, Myhre E. The effects of nifedipine, a calcium antagonist, on platelet function. American Heart Journal 105: 103–105, 1983

    Article  PubMed  CAS  Google Scholar 

  • Department of Health and Social Security. Report on confidential enquiries into maternal deaths in the United Kingdom 1985–87, pp. 17–27, Her Majesty’s Stationery Office, London, 1991

  • Dudley DKL. Minibolus diazoxide in the management of severe hypertension in pregnancy. American Journal of Obstetrics and Gynecology 151: 196–200, 1985

    PubMed  CAS  Google Scholar 

  • Dumez Y, Tchobroutsky C, Hornuch H, Amiel-Tison C. Neonatal effects of maternal administration of acebutolol. British Medical Journal 283: 1077–1079, 1981

    Article  PubMed  CAS  Google Scholar 

  • Editorial. Controlled intravascular sodium nitroprusside treatment. British Medical Journal 2: 783–784, 1978

  • Fiddler GI. Propranolol and pregnancy. Lancet 2: 722–723, 1974

    Article  PubMed  CAS  Google Scholar 

  • Fidler J, Smith V, Fayers P, de Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. British Medical Journal 286: 1927–1930, 1983

    Article  PubMed  CAS  Google Scholar 

  • Gallery DM, Ross MR, Gygory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. British Medical Journal 291: 563–566, 1985

    Article  PubMed  CAS  Google Scholar 

  • Garden A, Davey DA, Dommisse J. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. Clinical and Experimental Hypertension Part Bl (2 & 3): 371–383, 1982

    Google Scholar 

  • Gladstone GR, Hordof A, Gersony WM. Propranolol administration during pregnancy: effects on the fetus. Journal of Pediatrics 86: 962–964, 1975

    Article  PubMed  CAS  Google Scholar 

  • Goldby FS, Beilin LJ. How an acute rise in arterial pressure damages arterioles. Cardiovascular Research 6: 569–584, 1972

    Article  PubMed  CAS  Google Scholar 

  • Guignard JP, Burgener F, Calame A. Persistent anuria in a neonate: a side effect of captopril? International Journal of Pediatric Nephrology 2: 133, 1981

    Google Scholar 

  • Hanretty KP, Whittle MJ, Howie CA, Rubin PC. Effect of nifedipine on doppler flow velocity waveforms in severe preeclampsa. British Medical Journal 299: 1205–1206, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hans SF. Methyldopa in treatment of severe toxaemia of pregnancy. British Medical Journal 1: 736–739, 1964

    Article  PubMed  CAS  Google Scholar 

  • Hanssens M, Keirse MJNC, Vankelecom, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstetrics and Gynecology 78: 128–135, 1991

    PubMed  CAS  Google Scholar 

  • Harake B, Gilbert RD, Ashwal S, Power GG. Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep. American Journal of Obstetrics and Gynecology 157: 1003–1008, 1987

    PubMed  CAS  Google Scholar 

  • Henrich WL, Cronin R, Miller PD, Anderson RJ. Hypotensive sequelae of diazoxide and hydralazine therapy. Journal of the American Medical Association 237: 264–265, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hoffman BB, Lefkowitz RJ. Alpha-adrenergic receptor subtypes. New England Medical Journal 302: 1390–1396, 1980

    Article  CAS  Google Scholar 

  • Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. Journal of the American Medical Association 266: 261–265, 1991

    Google Scholar 

  • Jones HMR, Cummings AJ. A study of the transfer of α-methyldopa to the human foetus and newborn infant. British Journal of Clinical Pharmacology 6: 432–434, 1978

    Article  PubMed  CAS  Google Scholar 

  • Jouppila P, Kirkinen P, Koivula A, Ylikorkala O. Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids. Obstetrics and Gynecology 65: 115–118, 1985

    PubMed  CAS  Google Scholar 

  • Jouppila P, Kirkinen P, Koivula A, Ylikorkala O. Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia. British Journal of Obsterics and Gynaecology 93: 543–547, 1986

    Article  CAS  Google Scholar 

  • Kincaid-Smith P, Bullen M, Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. British Medical Journal 1: 274–276, 1966

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser J. β-Adrenoceptor antagonists: new drugs and new indications. New England Journal of Medicine 305: 500–505, 1981

    Article  PubMed  CAS  Google Scholar 

  • Ladner CN, Weston PV, Brinkman CR, Assali NS. Effects of hydralazine on uteroplacental and fetal circulations. American Journal of Obstetrics and Gynecology 108: 375–381, 1970

    PubMed  CAS  Google Scholar 

  • Larkin JG, Butler E, Brodie MJ. Nifedipine for epilepsy? A pilot study. British Medical Journal 296: 530–531, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lavies NG, Meiklejohn BH, May AE, Achola KJ, Fell D. Hypertensive and catecholamine response to tracheal intubation in patients with pregnancy-induced hypertension. British Journal of Anaesthesia 63: 429–434, 1989

    Article  PubMed  CAS  Google Scholar 

  • Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 2: 488–490, 1968

    Article  PubMed  CAS  Google Scholar 

  • Lindow S, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. British Journal of Obstetrics and Gynaecology 95: 1276–1281, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lubbe WF, Hodge JV. Combined α- and β-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. New Zealand Medical Journal 94: 169–172, 1981

    PubMed  CAS  Google Scholar 

  • Lunell NO, Lewander R, Nyland L, Sarby B, Thornstrom S. Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. Gynecologic and Obstetric Investigation 16: 274–282, 1983

    Article  PubMed  CAS  Google Scholar 

  • Lunell NO, Nyland L, Lewander R, Sarby B. Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow. British Journal of Obstetrics and Gynaecology 89: 640–644, 1982

    Article  PubMed  CAS  Google Scholar 

  • Lurie S, Fenakel K, Friedman A. Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension. American Journal of Perinatology 7: 285–286, 1990

    Article  PubMed  CAS  Google Scholar 

  • Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstetrics and Gynecology 70: 328–333, 1987

    PubMed  CAS  Google Scholar 

  • MacPherson M, Broughton-Pipkin F, Rutter N. The effect of maternal labetalol on the newborn infant. British Journal of Obstetrics and Gynaecology 93: 539–542, 1986

    Article  PubMed  CAS  Google Scholar 

  • Melander A, Niklasson B, Ingemarsson I, Liedholm H, Schersten B, et al. Transplacental passage of atenolol in man. European Journal of Clinical Pharmacology 14: 93–94, 1978

    Article  PubMed  CAS  Google Scholar 

  • Moar VA, Jefferies MA, Mutch LMM, Ounsted MK, Redman CWG. Neonatal head circumference and the treatment of maternal hypertension. British Journal of Obstetrics and Gynaecology 85: 933–937, 1978

    Article  PubMed  CAS  Google Scholar 

  • Moretti MM, Fairlie FM, Akl S, Khoury A, Sibai BM. The effect of nifedipine therapy on fetal and placental doppler waveforms in preeclampsia remote from term. American Journal of Obstetrics and Gynecology 163: 1844–1848, 1990

    PubMed  CAS  Google Scholar 

  • Morris JA, Arce JJ, Hamilton CJ, Davidson EC, Maidman JE, et al. The management of severe preeclampsia and eclampsia with intavenous diazoxide. Obstetrics and Gynecology 49: 675–580, 1977

    PubMed  CAS  Google Scholar 

  • Naulty JN, Cefalo RG, Lewis PE. Fetal toxicity of nitroprusside in the pregnant ewe. American Journal of Obstetrics and Gynecology 139: 708–711, 1981

    PubMed  CAS  Google Scholar 

  • Neuman J, Weiss B, Rabello Y, Cabal L, Freeman RK. Diazoxide for the acute control of severe hypertension complicating pregnancy: a pilot study. Obstetrics and Gynecology 53 (Suppl.): 50–55, 1979

    Google Scholar 

  • Parisi VM, Salinas J, Stockmar H. Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe. American Journal of Obstetrics and Gynecology 161: 1035–1039, 1989

    PubMed  CAS  Google Scholar 

  • Perry HM. Late toxicity to hydralazine resembling systemic lupus erythematosus of rheumatoid arthritis. American Journal of Medicine 54: 58–72, 1973

    Article  PubMed  Google Scholar 

  • Pickles CJ, Symonds EM, Broughton-Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 96: 38–43, 1989

    Article  PubMed  CAS  Google Scholar 

  • Plouin PF, Breart G, Llado J, Dalle M, Keller ME, et al. A randomized comparison of early with conservative use of anti-hypertensive drugs in the management of pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 97: 134–141, 1990

    Article  PubMed  CAS  Google Scholar 

  • Plouin PF, Breart G, Maillard F, Papiermik E, Relier JP. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. British Journal of Obstetrics and Gynaecology 95: 868–876, 1988

    Article  PubMed  CAS  Google Scholar 

  • Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. American Journal of Obstetrics and Gynecology 135: 485–489, 1979

    PubMed  CAS  Google Scholar 

  • Ram CV, Kaplan NM. Individual titration of diazoxide dosage in the treatment of severe hypertension. American Journal of Cardiology 43: 627–630, 1979

    Article  PubMed  CAS  Google Scholar 

  • Ramanathan J, Sibai BM, Mabie WC, Chauhan D, Ruiz AG. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. American Journal of Obstetrics and Gynecology 159: 650–654, 1988

    PubMed  CAS  Google Scholar 

  • Redman CWG. Platelets and the beginnings of preeclampsia. New England Journal of Medicine 323: 478–479, 1990

    Article  PubMed  CAS  Google Scholar 

  • Redman CWG. Controlled trials of antihypertensive drugs in pregnancy. American Journal of Kidney Diseases 17: 149–153, 1991a

    CAS  Google Scholar 

  • Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta 12: 301–308, 1991b

    Article  CAS  Google Scholar 

  • Redman CWG, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. British Journal of Obstetrics and Gynaecology 84: 419–426, 1977

    Article  PubMed  CAS  Google Scholar 

  • Redman CWG, Beilin LJ, Bonnar J, Ounsted MK. Fetal outcome trial of antihypertensive treatment in pregnancy. Lancet 2: 753–756, 1976a

    Article  CAS  Google Scholar 

  • Redman CWG, Beilin LJ, Bonnar J, Wilkinson RH. Plama urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1: 1370–1373, 1976b

    Article  CAS  Google Scholar 

  • Redman CWG, Kelly JG, Cooper WD. The excretion of enalapril and enalaprilat in human breast milk. European Journal of Clinical Pharmacology 38: 99–100, 1990

    Article  PubMed  CAS  Google Scholar 

  • Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Archives of Disease in Childhood 59: 1061–1063, 1984

    Article  PubMed  CAS  Google Scholar 

  • Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, et al. Preeclampsia: an endothelial disorder. American Journal of Obstetrics and Gynecology 161: 1200–1204, 1989

    PubMed  CAS  Google Scholar 

  • Rosa FW, Bosco LA, Graham CH. Neonatal anuria with maternal angiotensin-enzyme inhibition. Obstetrics and Gynecology 74: 371–374, 1989

    PubMed  CAS  Google Scholar 

  • Rubin PC. Beta-blockers in pregnancy. New England Journal of Medicine 305: 1323–1325, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rubin PC, Butters SCM, Clark D, Sumner D, Belfield A, et al. Obstetric aspects of the use in pregnancy-associated hypertension of the β-adrenoceptor antagonist atenolol. American Journal Obstetrics and Gynecology 150: 389–392, 1984

    CAS  Google Scholar 

  • Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1: 431–434, 1983a

    CAS  Google Scholar 

  • Rubin PC, Butters L, Low RA, Reid JL. Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension. British Journal Clinical Pharmacology 16: 543–547, 1983b

    Article  CAS  Google Scholar 

  • Rubin PC, Butters L, McCabe R. Nifedipine and platelets in preeclampsia. American Journal of Hypertension 1: 175–177, 1988

    PubMed  CAS  Google Scholar 

  • Shoemaker CT, Meyers M. Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity. American Journal of Obstetrics and Gynecology 149: 171–173, 1984

    PubMed  CAS  Google Scholar 

  • Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstetrics and Gynecology 70: 323–327, 1987

    PubMed  CAS  Google Scholar 

  • Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. American Journal of Obstetrics and Gynecology 150: 831–835, 1984

    PubMed  CAS  Google Scholar 

  • Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. American Journal of Obstetrics and Gynecology 162: 960–967, 1990

    PubMed  CAS  Google Scholar 

  • Suonio S, Saarikoski S, Tahvanainen K, Paakkonen A, Olkkonen H. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 155: 122–125, 1985

    Google Scholar 

  • Swales JD, Ramsay LE, Coope JR, Pocock J, Robertson JS, et al. Treating mild hypertension: agreement from the large trials. British Medical Journal 298: 696–696, 1989

    Article  Google Scholar 

  • Thien T, Koene RAP, Schijf C, Pieters GFFM, Eskes TKAB, et al. Infusion of dizoxide in severe hypertension during pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology 10: 367–374, 1980

    Article  CAS  Google Scholar 

  • Ulmsten U. Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist. Archives of Gynecology 236: 69–72, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ulmsten U, Andersson KE, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Archives of Gynecology 229: 1–5, 1980

    Article  PubMed  CAS  Google Scholar 

  • Veille JC, Bissonnette JM, Hohimer AR. The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat. American Journal of Obstetrics and Gynecology 154: 1160–1163, 1986

    PubMed  CAS  Google Scholar 

  • Vink J, Moodley J. The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. South African Medical Journal 62: 475–477, 1982

    PubMed  CAS  Google Scholar 

  • Vink GJ, Moodley J, Philpott RH. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstetrics and Gynecology 55: 519–523, 1980

    PubMed  CAS  Google Scholar 

  • Waisman GD, Mayorga LM, Camera MI, Vignolo CA, Martinotti A. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? American Journal of Obstetrics and Gynecology 159: 308–309, 1988

    PubMed  CAS  Google Scholar 

  • Walker JJ, Belch JJF, Erwin L, McLaren M, Lang G, et al. Labetalol and platelet function in pre-eclampsia. Lancet 2: 279, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1:1–3, 1986

    Article  PubMed  CAS  Google Scholar 

  • Walters BNJ, Redman CWG. Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. British Journal of Obstetrics and Gynaecology 91: 330–336, 1984

    Article  PubMed  CAS  Google Scholar 

  • Weitz C, Khouzami V, Maxwell K, Johnson JWC. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. International Journal of Gynaecology and Obstetrics 25: 35–40, 1987

    Article  PubMed  CAS  Google Scholar 

  • Whitelaw A. Maternal methldopa treatment and neonatal blood pressure. British Medical Journal 283: 471, 1981

    Article  PubMed  CAS  Google Scholar 

  • Wichman K, Ryden G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scandinavian Journal of Clinical Laboratory Investigation 44 (Suppl.): 90–95, 1984

    Article  Google Scholar 

  • Wide-Svensson D, Ingemarsson I, Arulkumaran S, Andersson KE. Effects of isradipine, a new calcium antagonist, on maternal cardiovascular system and uterine activity in labour. British Journal of Obstetrics and Gynaecology 97: 945–949, 1990

    Article  Google Scholar 

  • Yemini M, Shoham Z, Dgani R, Lancet M, Mogilner BM, et al. Lupus-like syndrome in a mother and newborn following administration of hydralazine: a case report. European Journal of Obstetrics, Gynecology and Reproductive Biology 30: 193–197, 1989

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Maternity Hospital, Oxford, OX3 9DU, England

    Phillipa M. Kyle & Christopher W. G. Redman

Authors
  1. Phillipa M. Kyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher W. G. Redman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kyle, P.M., Redman, C.W.G. Comparative Risk-Benefit Assessment of Drugs Used in the Management of Hypertension in Pregnancy. Drug-Safety 7, 223–234 (1992). https://doi.org/10.2165/00002018-199207030-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199207030-00007

Keywords

Search

Navigation